AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $183.13, giving the company a market capitalization of 281.47B. It carries a P/E multiple of 27.75 and pays a dividend yield of 1.7%.
On 2026-06-08, AstraZeneca(AZN) stock traded between a low of $181.36 and a high of $185.26. Shares are currently priced at $183.13, which is +1.0% above the low and -1.1% below the high.
AstraZeneca(AZN) shares are trading with a volume of 2.04M, against a daily average of 2.09M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
AZN News
Positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist, “unlock the next chapter in AstraZ...
...
Justin Smith, an analyst from Bernstein, maintained the Buy rating on AstraZeneca. The associated price target is p18,600.00. Unlock trusted, data-backed inves...
Analyst ratings
83%
of 29 ratingsMore AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst r...
Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst r...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst rating...
Analyst Sachin Jain from Bank of America Securities reiterated a Buy rating on AstraZeneca and keeping the price target at p16,500.00. Unlock trusted, data-bac...
• AstraZeneca stock is trending lower. Why are AZN shares declining? Updated SERENA-6 Data Reinforces Progression-Free Survival Benefit The updated analysis s...
Further positive results from the Phase III Serena-6 trial showed AstraZeneca’s (AZN) camizestrant plus a cyclin-dependent kinase, CDK, 4/6 inhibitor – palbocic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.